![Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData - Express Pharma Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData - Express Pharma](https://cdn.expresspharma.in/wp-content/uploads/2023/08/22151252/PR18116.jpg)
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData - Express Pharma
![Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent - SynBioBeta Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent - SynBioBeta](https://assets-global.website-files.com/62a66aa220a55155318447ce/62a66aa220a55179028467d0_Emily-Leproust.jpeg)
Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent - SynBioBeta
![Chris Bernatz on X: "Pershing Square highlights the razor/razor blade business model of Agilent ( $A ) What are some other non-obvious companies that leverage razor/razor blade business models? A few that Chris Bernatz on X: "Pershing Square highlights the razor/razor blade business model of Agilent ( $A ) What are some other non-obvious companies that leverage razor/razor blade business models? A few that](https://pbs.twimg.com/media/EW3XODFX0AEM1zc.png)
Chris Bernatz on X: "Pershing Square highlights the razor/razor blade business model of Agilent ( $A ) What are some other non-obvious companies that leverage razor/razor blade business models? A few that
![Agilent Technologies: Solid Operational Performance Paves The Way For The Future (NYSE:A) | Seeking Alpha Agilent Technologies: Solid Operational Performance Paves The Way For The Future (NYSE:A) | Seeking Alpha](https://static.seekingalpha.com/uploads/2023/7/16/saupload_OMCVD01YHejsM6UwNhnQFkvEwmUofaOlGBCnYfIFs_pRHKPyh3Fp6Kh5hX4eWPbVFBRLqMczKqLFkipRe5BCf86XDjMPekSGXpz6eqq_80BVPlw956ccCkVxYR1U7_f2vavyRG49nU2CscYM2eNwmOU.png)